Stock quote - Summary

AGL: 47.00 -1.00 ( -2.08 %) delayed: 10:06AM
Bid price 46.00 High price 47.65
Ask price 48.00 Low price 46.26
Open price 47.65 Spread 4.17%
Prev close 48.00 Volume 30,872

Angle - Share price charts

Historic - 6 months

Advanced Angle charts >

Angle - Share price information
Name Angle Epic AGL
Activities ANGLE plc is a world-leading liquid biopsy company commercialising a disruptive platform technology that can capture cells circulating in blood, such as cancer cells, even when they are as rare in number as one cell in one billion blood cells, and harvest the cells for analysis. ANGLE's cell separation technology is called the ParsortixTM system and it enables a liquid biopsy (simple blood test) to be used to provide the cells of interest. Parsortix is the subject of granted patents in Europe, the United States, Canada, India, China, Japan and Australia and three extensive families of patents are being progressed worldwide. The system is based on a microfluidic device that captures live cells based on a combination of their size and compressibility. The ParsortixTM system has a CE Mark for Europe and FDA authorisation is in process for the United States. ANGLE has established formal collaborations with world-class cancer centres. ISIN GB0034330679
Latest Share Price (p) 47.00 Net Gearing (%) -31.36
Market Capitalisation (pm) 56.20 Gross Gearing (%) 19.34
Shares in issue (m) 117.09 Debt Ratio 0.00
P/E Ratio -5.51 Debt-to-Equity Ratio 0.00
Total dividends per share (p) 0.00 Assets / Equity Ratio 1.24
Dividend Yield (%) 0.00 Price to book value 6.38
Dividend Cover 0.00 ROCE (%) -84.11
Earning per share (p) -8.71 EPS Growth (%) -0.81
52-week high / low (p) 80.00 / 32.25 DPS Growth (%) n/a
Angle - Broker views
Date Broker Recommendation Price Old target price New target price Notes
12 Feb finnCap Corporate 108.00 108.00 Reiterates
31 Jan finnCap Corporate 108.00 108.00 Reiterates
08 Jan finnCap Corporate 108.00 108.00 Reiterates
23 Nov finnCap Corporate 108.00 108.00 Reiterates
21 Nov finnCap Corporate 108.00 108.00 Reiterates

More Angle broker views >

Angle - Director deals
Date Director Type Volume / Price Trade value
24 Sep 2009 Andrew Newland Buy 200,000 @ 15.25p £30,500.00

More Angle director deals >

Risk warning: Remember the price of shares can go down as well as up, and you are not guaranteed to get back the amount that you originally invested.
Click here to read the full warning.